I generally agree, @fattchoi. The massive dip however does...

I generally agree, @fattchoi. The massive dip however does demonstrate how fragile the share price is for Imugene. I haven't observed such a massive drop based on public sentiment except for the likes of cryptocurrencies and sellers succumbing to trash tweets. If one ambiguous article from AFR can reverse the gains achieved over the past few months, I think it's reasonable for others to assess whether they are willing to ride the waves.

I believe in the science of Imugene as each clinical trial has been strongly evidence-based by robust pre-clinical research publications but even I was tempted to sell as soon as I saw the drop. However, I'm cautiously holding on as the 12 months should yield some additional announcements that should hopefully see the share price recovery.

To be honest, I'm still not across the suspicion around Leslie's shares and options. Can anyone help me understand why the noise around her shareholding news?

Thanks.